Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novartis files sNDA for Zometa showing long-term benefit

Oct. 22, 2002

Protection against cisplatin nephrotoxicity in rodents treated with BGP-15

Oct. 22, 2002

First E.U. trial of DTI-015 cleared to begin in U.K.

Oct. 22, 2002

Arius and Xerion form colorectal cancer collaboration

Oct. 22, 2002

Protein Design Labs to evaluate two Arius anticancer antibodies

Oct. 22, 2002

Well-established antiparasitic agent now reported to possess potent antitumor activity

Oct. 21, 2002

Novel antiproliferative macrolides prepared by Kosan researchers

Oct. 21, 2002

Antitumor activity of IDN-5109 against hormone-refractory prostate cancer

Oct. 21, 2002

Antimyeloma efficacy of PS-341 in a human plasmacytoma xenograft model

Oct. 21, 2002

Three series of MMP inhibitors prepared and tested at former Warner-Lambert

Oct. 21, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.